TITLE:
Treatment Program for Anemia in AIDS Patients

CONDITION:
HIV Infections

INTERVENTION:
Epoetin alfa

SUMMARY:

      The objective of the Eprex (erythropoietin) Treatment Program is to provide erythropoietin
      for the treatment of anemia in AIDS patients.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 12 Years to N/A
Criteria:

        Exclusion Criteria

        Co-existing Condition:

        Patients with the following are excluded:

          -  Life expectancy < 3 months.

          -  = or < grade 4 performance score.

          -  AIDS-related dementia.

          -  Uncontrolled hypertension.

          -  Acute symptomatic opportunistic infection or other AIDS-defining illness.

        Patients with the following are excluded:

          -  Life expectancy < 3 months.

          -  = or < grade 4 performance score.

          -  AIDS-related dementia.

          -  Uncontrolled hypertension.

          -  Acute symptomatic opportunistic infection or other AIDS-defining illness.

        Patients must have:

          -  A clinical diagnosis of AIDS.

          -  Hematocrit < 30 percent.

          -  Endogenous serum erythropoietin level = or < 500 U/ml.

          -  A life expectancy = or > 3 months.

          -  > Grade 4 performance score.
      
